SCHEMBL21600432

SCHEMBL21600432

Cc1ccccc1-c1c(C)ccc2c1oc1c2ccc2[nH]c3ccccc3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 4/20 0.44
▸ GABRD O14764 4/20 0.44
▸ GABRA1 P14867 4/20 0.44
▸ GABRB1 P18505 4/20 0.44
▸ GABRG2 P18507 4/20 0.44
▸ GABRB3 P28472 4/20 0.44
▸ GABRA5 P31644 4/20 0.44
▸ GABRA3 P34903 4/20 0.44
▸ GABRA2 P47869 4/20 0.44
▸ GABRB2 P47870 4/20 0.44
▸ GABRA4 P48169 4/20 0.44
▸ GABRE P78334 4/20 0.44
▸ GABRA6 Q16445 4/20 0.44
▸ GABRG1 Q8N1C3 4/20 0.44
▸ GABRG3 Q99928 4/20 0.44
▸ GABRQ Q9UN88 4/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20808644 0.83 MEN1 (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16484309 0.81 GABRA1 (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL21726235 0.78 PARP1 (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL24860213 0.76 GABRP (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16440351 0.76 PARP1 (0.39) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL14951613 0.75 GABRA1 (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL24417328 0.75 GABRP (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL19573737 0.73 CDK4 (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31846 0.72 GABRA1 (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29655467 0.72 GABRA1 (0.51) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11552258-B2 Organic light-emitting device comprising emission layer satisfying specific singlet excitation energy level conditions SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-10 — — US disclosed
US-20190393424-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-12-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552258-B2 Organic light-emitting device comprising emission layer satisfying specific singlet excitation energy level conditions EML4, NES, TBL2 GABRP 4538/4885GABRD 4479/4885GABRA1 3818/4885
US-20190393424-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, LIN28A, OR51E2 GABRP 3852/4885GABRD 2105/4885GABRA1 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback